Main Article Content

Sudhair Abbas Bangash
Dr. Syed Sikandar Shah
Sidra Hassan
Md Moktadirul Alam
Muhammad Umar
Dr. Rebecca Caruana
Dr. Abdalrahim A.M Bsharat
Dr. Saja Khalid Ahmed Al-Abbasi
Tariq Rafique


Parkinson's, Nutritional approach, Dysphagia, Food supplements


Introduction: Malnutrition in the context of Parkinson's disease involves both excess and deficiency, with deficiency recognized as a prominent global cause of immunodeficiency. Various risk factors, including weight loss, levodopa treatment duration, anxiety, and symptoms related to dysautonomia, contribute to malnutrition in Parkinson's patients.

Objective: This study aims to delineate the impact of nutritional interventions on individuals with neurodegenerative Parkinson's disease.

Methodology: Conducted as a retrospective descriptive bibliographic review, the study involves a comprehensive search and analysis of original scientific articles in Spanish and English. Medical information databases such as PubMed, Web of Science, BVS, Scholar, Medline, SciELO, etc., were utilized for article selection.

Results: Out of 37 screened scientific articles, nine high-level evidence surveys were included, following predefined inclusion and exclusion criteria. The nutritional approach to Parkinson's involves guided diets tailored to the patient's nutritional status and disease progression. The Mediterranean diet emerges as a well-supported option for nutritional support in Parkinson's, along with recommendations for diet modification in the consistency of both liquids and solids.

Conclusion: This review underscores the importance of addressing malnutrition in Parkinson's disease through a targeted nutritional approach. Guided diets, especially those aligned with the principles of the Mediterranean diet, are recognized as valuable strategies. Modification of diet consistency, considering the progression of the disease, further adds to the nuanced nutritional management of Parkinson's patients.

Abstract 426 | pdf Downloads 154


1. Al-Hakeem, H., Zhang, Z., DeMarco, E. C., Bitter, C. C., & Hinyard, L. (2024). Emergency department visits in Parkinson's disease: The impact of comorbid conditions. The American Journal of Emergency Medicine, 75, 7-13.
2. Arunachalam, K. D., Saranya, S., & Karuppannan, S. K. (2024). Role of dietary fibres in the management of hypertension and its association with neurodegeneration Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 261-275): Elsevier.
3. Banou, E., Vrahatis, A. G., Krokidis, M. G., & Vlamos, P. (2024). Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease. BioMedInformatics, 4(1), 127-138.
4. Bartolomeu Pires, S., Kunkel, D., Kipps, C., Goodwin, N., & Portillo, M. C. (2024). Person‐centred integrated care for people living with Parkinson's, Huntington's and Multiple Sclerosis: A systematic review. Health Expectations, 27(1), e13948.
5. Cabanillas, J., Risco, R., Munive-Degregori, A., Guerrero, M. E., Mauricio, F., & Mayta-Tovalino, F. Periodontitis and neuropathic diseases: A literature review. Journal of International Society of Preventive and Community Dentistry, 10.4103.
6. Caminiti, S. P., Gallo, S., Menegon, F., Naldi, A., Comi, C., & Tondo, G. (2024). Lifestyle Modulators of Neuroplasticity in Parkinson’s Disease: Evidence in Human Neuroimaging Studies. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
7. Chen, S. T., & Small, G. W. (2024). Precision Nutrition in Aging and Brain Health Precision Nutrition (pp. 241-276): Elsevier.
8. Cheng, W.-H., Quan, Y., & Thompson, W. F. (2024). The Effect of Dance on Mental Health and Quality of Life of People with Parkinson's Disease: A Systematic Review and Three-level Meta-Analysis. Archives of Gerontology and Geriatrics, 105326.
9. Chiang, L., Cheong, D., Cordato, N. J., & Smerdely, P. (2024). A systematic review of visual art therapy and its effects in older people with mild cognitive impairment. International Journal of Geriatric Psychiatry, 39(1), e6053.
10. Ciocca, M., & Pizzamiglio, C. (2024). Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson’s Disease Patients. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
11. Dagar, K., Asati, V., Bharti, S. K., Suryavanshi, A., Shukla, D., Mahapatra, D. K., & Kumar, V. (2024). Functional food for mitochondrial dysfunction and autophagy in neurodegenerative diseases Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 31-61): Elsevier.
12. Delafontaine, A., Vialleron, T., Barbier, G., Lardon, A., Barrière, M., García-Escudero, M., . . . Descarreaux, M. (2024). Effects of Manual Therapy on Parkinson’s Gait: A Systematic Review. Sensors, 24(2), 354.
13. Duvdevani, M., Yogev-Seligmann, G., Schlesinger, I., Nassar, M., Erich, I., Hadad, R., & Kafri, M. (2024). Association of health behaviors with function and health-related quality of life among patients with Parkinson’s disease. Israel Journal of Health Policy Research, 13(1), 1-10.
14. Farombi, E. O., Ajeigbe, O. F., Anamelechi, J., Adeyemo, O., Ojo, M. O., Atarase, O., & Ikeji, C. N. (2024). Neuroprotection by ginger and its components in neurodegenerative diseases Natural Molecules in Neuroprotection and Neurotoxicity (pp. 1525-1543): Elsevier.
15. Federico, S., Cacciante, L., Cieślik, B., Turolla, A., Agostini, M., Kiper, P., & Picelli, A. (2024). Telerehabilitation for Neurological Motor Impairment: A Systematic Review and Meta-Analysis on Quality of Life, Satisfaction, and Acceptance in Stroke, Multiple Sclerosis, and Parkinson’s Disease. Journal of Clinical Medicine, 13(1), 299.
16. Golpour-Hamedani, S., Pourmasoumi, M., Zarifi, S. H., Askari, G., Jamialahmadi, T., Bagherniya, M., & Sahebkar, A. (2024). Therapeutic effects of saffron and its components on neurodegenerative diseases. Heliyon.
18. Helgudóttir, S. S., Mørkholt, A. S., Lichota, J., Bruun-Nyzell, P., Andersen, M. C., Kristensen, N. M. J., . . . Nieland, J. D. V. (2024). Rethinking neurodegenerative diseases: neurometabolic concept linking lipid oxidation to diseases in the central nervous system. Neural Regeneration Research, 19(7), 1437-1445.
19. Hiu, S., Yong, T., Hasoon, J., Teare, M. D., Taylor, J. P., & Lin, N. (2024). Instrumental variables in real‐world clinical studies of dementia and neurodegenerative disease: Systematic review of the subject‐matter argumentation, falsification test, and study design strategies to justify a valid instrument. Brain and Behavior, 14(1), e3371.
20. Karande, S., & Kulkarni, V. (2024). Advancing Neurodegenerative Disorder Diagnosis: A Machine Learning-Driven Evaluation of Assessment Modalities. International Journal of Intelligent Systems and Applications in Engineering, 12(5s), 309-323.
21. Katiyar, S., Kumari, S., Dev, A., Tripathi, R. S., Srivastava, P. K., & Mishra, A. (2024). Herbal Nanoparticles Drug-Loaded for the Treatment of Neurodegenerative Diseases. Nanoarchitectonics for Brain Drug Delivery, 266.
22. Kezele, T. G., & Ćurko-Cofek, B. (2024). Neuroprotection induced by olive oil components Natural Molecules in Neuroprotection and Neurotoxicity (pp. 1679-1702): Elsevier.
23. Kluger, B. M., Katz, M., Galifianakis, N. B., Pantilat, S. Z., Hauser, J. M., Khan, R., . . . Long, S. J. (2024). Patient and Family Outcomes of Community Neurologist Palliative Education and Telehealth Support in Parkinson Disease. JAMA neurology, 81(1), 39-49.
24. Leonard, H., Jonson, C., Levine, K., Lake, J., Hertslet, L., Jones, L., . . . Terry, N. (2024). Assessing the lack of diversity in genetics research across neurodegenerative diseases: a systematic review of the GWAS Catalog and literature. medRxiv, 2024.2001. 2008.24301007.
25. Levi, S., Ripamonti, M., Moro, A. S., & Cozzi, A. (2024). Iron imbalance in neurodegeneration. Molecular Psychiatry, 1-14.
26. Liang, J., Wan, Z., Qian, C., Rasheed, M., Cao, C., Sun, J., . . . Deng, Y. (2024). The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson’s disease. Cellular & Molecular Biology Letters, 29(1), 1-24.
27. Liu, J., Lv, X., Ye, T., Zhao, M., Chen, Z., Zhang, Y., . . . Chen, L. (2024). Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach. Brain, Behavior, and Immunity.
28. Liu, X., Liu, Y., Liu, J., Zhang, H., Shan, C., Guo, Y., . . . Tang, M. (2024). Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence. Neural Regeneration Research, 19(4), 833-845.
29. Mazzucca, C. B., Cappellano, G., & Chiocchetti, A. (2024). Nutrition, Immunity and Aging: Current Scenario and Future Perspectives in Neurodegenerative Diseases. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
30. Mohamed, W. M. Y. (2024). Connecting the Dots: AfrAbia's Environmental Challenges and Parkinson's Disease.
31. Pandit, N., Kulkarni, S., & Singhvi, G. (2024). Effect of green tea on human brain health Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 301-331): Elsevier.
32. Parihar, A., Gaur, K., & Khan, R. (2024). Rapid diagnostic assays for the detection of Alzheimer’s and Parkinson’s diseases Smart Diagnostics for Neurodegenerative Disorders (pp. 221-250): Elsevier.
33. Pigott, J. S., Davies, N., Chesterman, E., Read, J., Nimmons, D., Walters, K., . . . Schrag, A. (2024). Compound impact of cognitive and physical decline: A qualitative interview study of people with Parkinson's and cognitive impairment, caregivers and professionals. Health Expectations, 27(1), e13950.
34. Rafe, M. R. (2024). Drug delivery for neurodegenerative diseases is a problem, but lipid nanocarriers could provide the answer. Nanotheranostics, 8(1), 90.
35. Shafiee, A., Rafiei, M. A., Jafarabady, K., Eskandari, A., Abhari, F. S., Sattari, M. A., . . . Bakhtiyari, M. (2024). Effect of cannabis use on blood levels of brain‐derived neurotrophic factor (BDNF) and nerve growth factor (NGF): A systematic review and meta‐analysis. Brain and Behavior, 14(1), e3340.
36. Shukla, D., Jaiswal, A. K., Suryavanshi, A., Asati, V., Mahapatra, D. K., Kumar, V., & Bharti, S. K. (2024). Role of garlic and onion for better cognition and maintenance of neurodegenerative diseases Nutraceutical Fruits and Foods for Neurodegenerative Disorders (pp. 333-352): Elsevier.
37. Suryawanshi, M. V., Gujarathi, P. P., Mulla, T., & Bagban, I. (2024). Hypericum perforatum: a comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases. Naunyn-Schmiedeberg's Archives of Pharmacology, 1-16.
38. Tasleem, A., Kaushik, M., Kaushik, P., Tabassum, H., & Parvez, S. (2024). Neuroprotective efficacy of melatonin in the pathophysiology of neurodegenerative disorders Natural Molecules in Neuroprotection and Neurotoxicity (pp. 615-633): Elsevier.
39. Tosin, M. H., Goetz, C. G., & Stebbins, G. T. (2024). Patient With Parkinson Disease and Care Partner Perceptions of Key Domains Affecting Health-Related Quality of Life: Systematic Review. Neurology, 102(3), e208028.
40. Wang, H., Liu, Y.-T., Ren, Y.-L., Guo, X.-Y., & Wang, Y. (2024). Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis. Journal of Neuroimmunology, 578290.
41. Wei, B.-r., Zhao, Y.-j., Cheng, Y.-f., Huang, C., & Zhang, F. (2024). Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability. Immunity & Ageing, 21(1), 1.

Most read articles by the same author(s)

1 2 3 4 > >>